U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

Showing 281 - 290 of 343 results

Status:
Possibly Marketed Outside US
Source:
NCT00126308: Phase 4 Interventional Terminated HIV-Associated Lipodystrophy
(2005)
Source URL:

Class:
POLYMER

Status:
Possibly Marketed Outside US
Source:
UK NHS:Carmellose sodium
Source URL:
First approved in 1984

Class:
POLYMER

Status:
Possibly Marketed Outside US
Source:
Canada:GLYCOSAMINOGLYCAN POLYSULPHATE
Source URL:

Class:
POLYMER

Showing 281 - 290 of 343 results